# Vector Science and Therapeutics Corp. (TSXV:PAIN) Gains Momentum as Peptide Commercialization and Therapeutic Innovation Support Sentiment - kalkine.ca

*Источник: kalkine.ca*
*Дата: 2026-09-28*
*Язык: en*

<a href="https://news.google.com/rss/articles/CBMi_gFBVV95cUxPcXd4SWZHRjBSX00yNm1XeVpRdUF0QjhyT1o1WHRxcF85SVQ2dXpNdy0teGpCVHBQMDFyZ3p2UXdnNUFmMFZiNy1DdFBoQVBUNUFzcmZCNEpZa0JINnJqY1RLWk9ubWFBXzRaaHFUc0JRa2V2V0kxaGo1U3dZd2I0d3RKR3NJSm9IQ0U3cE1LSTFmV2lTYXNtOV90UkZldmJOZldCR1NkSWN0Z3FlVzdkdEtPQ2V3VkFxUV9TWkRwb1dyUVB0OG82ZHo5cDNYMFJFN3M2Q0Jobm0xdW9wSTNRQlRoSmMwbk5KcGVaaV9tVG9xOXBTcC1vN0dSbUFNdw?oc=5" target="_blank">Vector Science and Therapeutics Corp. (TSXV:PAIN) Gains Momentum as Peptide Commercialization and Therapeutic Innovation Support Sentiment</a>&nbsp;&nbsp;<font color="#6f6f6f">kalkine.ca</font>

[Оригинал](https://kalkine.ca/news/healthcare/vector-science-and-therapeutics-corp-tsxvpain-gains-momentum-as-peptide-commercialization-and-therapeutic-innovation-support-sentiment)